Necessity of carbapenem use when prescribed per infectious diseases specialists
- 25 February 2017
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 88 (1) , 41-46
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A Systematic Review and Meta-Analyses Show that Carbapenem Use and Medical Devices Are the Leading Risk Factors for Carbapenem-Resistant Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2014
- Impact of extended‐spectrum β‐lactamase–producing organisms on clinical and economic outcomes in patients with urinary tract infectionJournal of Hospital Medicine, 2014
- Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2011-2012)Antimicrobial Agents and Chemotherapy, 2013
- Decreased Resistance of Pseudomonas aeruginosa with Restriction of Ciprofloxacin in a Large Teaching Hospital's Intensive Care and Intermediate Care UnitsInfection Control & Hospital Epidemiology, 2012
- Emergence of Klebsiella pneumoniae Carbapenemase-Producing BacteriaSouthern Medical Journal, 2011
- Relationship of Carbapenem Restriction in 22 University Teaching Hospitals to Carbapenem Use and Carbapenem-Resistant Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2009
- Electronic antibiotic stewardship--reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital settingJournal of Antimicrobial Chemotherapy, 2008
- Resistance in Gram-Negative Bacteria: EnterobacteriaceaeThe American Journal of Medicine, 2006
- A Review of Evidence Supporting the American Academy of Pediatrics Recommendation for Prescribing Cephalosporin Antibiotics for Penicillin-Allergic PatientsPediatrics, 2005
- The impact of antibiotic use on resistance development and persistenceDrug Resistance Updates, 2000